FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:MPRIP-BAZ2A

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: MPRIP-BAZ2A
FusionPDB ID: 54773
FusionGDB2.0 ID: 54773
HgeneTgene
Gene symbol

MPRIP

BAZ2A

Gene ID

23164

11176

Gene namemyosin phosphatase Rho interacting proteinbromodomain adjacent to zinc finger domain 2A
SynonymsM-RIP|MRIP|RHOIP3|RIP3|p116RipTIP5|WALp3
Cytomap

17p11.2

12q13.3

Type of geneprotein-codingprotein-coding
Descriptionmyosin phosphatase Rho-interacting proteinRho interacting protein 3bromodomain adjacent to zinc finger domain protein 2ATTF-I interacting peptide 5TTF-I-interacting protein 5transcription termination factor I-interacting protein 5
Modification date2020031320200313
UniProtAcc

Q6WCQ1

Main function of 5'-partner protein: FUNCTION: Targets myosin phosphatase to the actin cytoskeleton. Required for the regulation of the actin cytoskeleton by RhoA and ROCK1. Depletion leads to an increased number of stress fibers in smooth muscle cells through stabilization of actin fibers by phosphorylated myosin. Overexpression of MRIP as well as its F-actin-binding region leads to disassembly of stress fibers in neuronal cells. {ECO:0000250|UniProtKB:P97434, ECO:0000269|PubMed:15545284, ECO:0000269|PubMed:16257966}.

Q9UIF9

Main function of 5'-partner protein: FUNCTION: Essential component of the NoRC (nucleolar remodeling complex) complex, a complex that mediates silencing of a fraction of rDNA by recruiting histone-modifying enzymes and DNA methyltransferases, leading to heterochromatin formation and transcriptional silencing. In the complex, it plays a central role by being recruited to rDNA and by targeting chromatin modifying enzymes such as HDAC1, leading to repress RNA polymerase I transcription. Recruited to rDNA via its interaction with TTF1 and its ability to recognize and bind histone H4 acetylated on 'Lys-16' (H4K16ac), leading to deacetylation of H4K5ac, H4K8ac, H4K12ac but not H4K16ac. Specifically binds pRNAs, 150-250 nucleotide RNAs that are complementary in sequence to the rDNA promoter; pRNA-binding is required for heterochromatin formation and rDNA silencing (By similarity). {ECO:0000250}.
Ensembl transtripts involved in fusion geneENST idsENST00000341712, ENST00000395804, 
ENST00000395811, ENST00000444976, 
ENST00000395806, ENST00000395807, 
ENST00000553222, ENST00000179765, 
ENST00000379441, ENST00000549884, 
ENST00000551812, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score24 X 12 X 11=31689 X 9 X 4=324
# samples 239
** MAII scorelog2(23/3168*10)=-3.78386656913523
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(9/324*10)=-1.84799690655495
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: MPRIP [Title/Abstract] AND BAZ2A [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: MPRIP [Title/Abstract] AND BAZ2A [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)MPRIP(17083402)-BAZ2A(56999111), # samples:1
Anticipated loss of major functional domain due to fusion event.MPRIP-BAZ2A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
MPRIP-BAZ2A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
MPRIP-BAZ2A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
MPRIP-BAZ2A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:17083402/chr12:56999111)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across MPRIP (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across BAZ2A (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000395811MPRIPchr1717083402+ENST00000379441BAZ2Achr1256999111-937531348963522087
ENST00000395811MPRIPchr1717083402+ENST00000179765BAZ2Achr1256999111-937531348963522087
ENST00000395811MPRIPchr1717083402+ENST00000551812BAZ2Achr1256999111-904131348963522087
ENST00000395811MPRIPchr1717083402+ENST00000549884BAZ2Achr1256999111-660231348963522087
ENST00000444976MPRIPchr1717083402+ENST00000379441BAZ2Achr1256999111-925230118062292049
ENST00000444976MPRIPchr1717083402+ENST00000179765BAZ2Achr1256999111-925230118062292049
ENST00000444976MPRIPchr1717083402+ENST00000551812BAZ2Achr1256999111-891830118062292049
ENST00000444976MPRIPchr1717083402+ENST00000549884BAZ2Achr1256999111-647930118062292049
ENST00000395804MPRIPchr1717083402+ENST00000379441BAZ2Achr1256999111-934231015663192087
ENST00000395804MPRIPchr1717083402+ENST00000179765BAZ2Achr1256999111-934231015663192087
ENST00000395804MPRIPchr1717083402+ENST00000551812BAZ2Achr1256999111-900831015663192087
ENST00000395804MPRIPchr1717083402+ENST00000549884BAZ2Achr1256999111-656931015663192087
ENST00000341712MPRIPchr1717083402+ENST00000379441BAZ2Achr1256999111-92863045062632087
ENST00000341712MPRIPchr1717083402+ENST00000179765BAZ2Achr1256999111-92863045062632087
ENST00000341712MPRIPchr1717083402+ENST00000551812BAZ2Achr1256999111-89523045062632087
ENST00000341712MPRIPchr1717083402+ENST00000549884BAZ2Achr1256999111-65133045062632087

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000395811ENST00000379441MPRIPchr1717083402+BAZ2Achr1256999111-0.0007750930.9992249
ENST00000395811ENST00000179765MPRIPchr1717083402+BAZ2Achr1256999111-0.0007750930.9992249
ENST00000395811ENST00000551812MPRIPchr1717083402+BAZ2Achr1256999111-0.0008955470.99910444
ENST00000395811ENST00000549884MPRIPchr1717083402+BAZ2Achr1256999111-0.0057696730.9942304
ENST00000444976ENST00000379441MPRIPchr1717083402+BAZ2Achr1256999111-0.0007732190.9992268
ENST00000444976ENST00000179765MPRIPchr1717083402+BAZ2Achr1256999111-0.0007732190.9992268
ENST00000444976ENST00000551812MPRIPchr1717083402+BAZ2Achr1256999111-0.00089520.9991048
ENST00000444976ENST00000549884MPRIPchr1717083402+BAZ2Achr1256999111-0.0059082510.9940917
ENST00000395804ENST00000379441MPRIPchr1717083402+BAZ2Achr1256999111-0.0007416570.99925834
ENST00000395804ENST00000179765MPRIPchr1717083402+BAZ2Achr1256999111-0.0007416570.99925834
ENST00000395804ENST00000551812MPRIPchr1717083402+BAZ2Achr1256999111-0.000858020.99914193
ENST00000395804ENST00000549884MPRIPchr1717083402+BAZ2Achr1256999111-0.0055900070.99441
ENST00000341712ENST00000379441MPRIPchr1717083402+BAZ2Achr1256999111-0.0006562350.9993437
ENST00000341712ENST00000179765MPRIPchr1717083402+BAZ2Achr1256999111-0.0006562350.9993437
ENST00000341712ENST00000551812MPRIPchr1717083402+BAZ2Achr1256999111-0.0007549520.99924505
ENST00000341712ENST00000549884MPRIPchr1717083402+BAZ2Achr1256999111-0.0048843390.99511564

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for MPRIP-BAZ2A

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
MPRIPchr1717083402BAZ2Achr12569991113011977SCVTRQLRNIRSKPLPDFSRVPGLTL
MPRIPchr1717083402BAZ2Achr125699911130451015SCVTRQLRNIRSKPLPDFSRVPGLTL
MPRIPchr1717083402BAZ2Achr125699911131011015SCVTRQLRNIRSKPLPDFSRVPGLTL
MPRIPchr1717083402BAZ2Achr125699911131341015SCVTRQLRNIRSKPLPDFSRVPGLTL

Top

Potential FusionNeoAntigen Information of MPRIP-BAZ2A in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
MPRIP-BAZ2A_17083402_56999111.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B27:05IRSKPLPDF0.99840.8501918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B27:02IRSKPLPDF0.99840.6085918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B27:04IRSKPLPDF0.99810.7322918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B14:02LRNIRSKPL0.97940.6437615
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B14:01LRNIRSKPL0.97940.6437615
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-A30:08RSKPLPDFSR0.99360.87441020
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-A74:03RSKPLPDFSR0.98920.81721020
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-A74:11RSKPLPDFSR0.98920.81721020
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-A74:09RSKPLPDFSR0.98920.81721020
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-A31:02RSKPLPDFSR0.97430.82031020
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-A31:06RSKPLPDFSR0.90140.76891020
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-C07:05IRSKPLPDF0.98560.9648918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-C07:95IRSKPLPDF0.98210.6781918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-C07:27IRSKPLPDF0.97350.9531918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-C07:29IRSKPLPDF0.93940.92918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B27:03IRSKPLPDF0.9370.8657918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B51:07KPLPDFSRV0.90560.81151221
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B39:12LRNIRSKPL0.90490.8338615
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B07:12KPLPDFSRV0.89420.61571221
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-C07:19IRSKPLPDF0.81620.7162918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-C07:80IRSKPLPDF0.80240.9438918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-C07:67IRSKPLPDF0.80240.9438918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-C07:46IRSKPLPDF0.79760.8836918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-C07:10IRSKPLPDF0.79250.9648918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-C07:13IRSKPLPDF0.76570.925918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B14:03LRNIRSKPL0.52180.7678615
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B42:02KPLPDFSRV0.35350.84461221
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B42:01KPLPDFSRV0.28360.8381221
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B39:10KPLPDFSRV0.26350.94031221
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-C12:16IRSKPLPDF0.01760.9514918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-A31:01RSKPLPDFSR0.98970.79411020
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B27:08IRSKPLPDF0.99830.7776918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B27:10IRSKPLPDF0.99820.8265918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B27:06IRSKPLPDF0.99770.7262918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B27:09IRSKPLPDF0.99030.7878918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-C07:01IRSKPLPDF0.98910.5954918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-C07:17IRSKPLPDF0.90610.9571918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-C07:02IRSKPLPDF0.80240.9438918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B35:13KPLPDFSRV0.73380.92671221
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-C06:08IRSKPLPDF0.66370.9778918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-C07:22IRSKPLPDF0.65550.7214918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B67:01KPLPDFSRV0.33880.83031221
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-C06:06IRSKPLPDF0.13260.9866918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-C06:02IRSKPLPDF0.01170.9894918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-C06:17IRSKPLPDF0.01170.9894918
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-A30:01RSKPLPDFSR0.99380.93741020
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-A74:01RSKPLPDFSR0.98920.81721020
MPRIP-BAZ2Achr1717083402chr12569991113045HLA-B59:01RSKPLPDFSRV0.87030.52991021

Top

Potential FusionNeoAntigen Information of MPRIP-BAZ2A in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
MPRIP-BAZ2A_17083402_56999111.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0103TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0103VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0123TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0123VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0701VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0701TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0703VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0703TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0704VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0705VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0705TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0706VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0706TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0707VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0707TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0708VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0708TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0709VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0709TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0711VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0711TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0712VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0712TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0713VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0713TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0714VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0714TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0715VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0715TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0716VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0716TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0717VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0717TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0719VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0719TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0819VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-0819TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1208TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1208VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1213TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1213VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1215TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1215VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1218TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1218VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1219TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1219VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1220TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1220VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1221TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1221VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1223TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1223VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1457VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1501TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1501VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1504VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1504TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1505TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1505VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1506TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1506VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1507TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1507VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1509TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1509VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1510TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1510VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1511TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1511VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1513TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1513VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1515VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1515TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1516TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1516VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1518TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1518VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1520TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1520VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1521TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1521VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1522TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1522VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1523VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1523TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1524TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1524VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1525TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1528TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1528VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1529VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1529TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1532TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1532VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1533TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1533VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1535TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1535VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1536TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1536VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1537TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1537VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1540TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1540VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1541TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1541VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1542TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1542VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1543TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1543VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1545TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1545VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1546TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1546VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1548TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1548VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1549TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1549VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1601TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1601VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1602TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1602VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1603TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1603VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1604TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1604VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1605TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1605VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1607TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1607VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1608TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1608VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1609TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1609VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1610TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1610VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1611TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1611VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1612TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1612VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1614TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1614VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1615TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1615VTRQLRNIRSKPLPD217
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1615CVTRQLRNIRSKPLP116
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1615RQLRNIRSKPLPDFS419
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1616TRQLRNIRSKPLPDF318
MPRIP-BAZ2Achr1717083402chr12569991113045DRB1-1616VTRQLRNIRSKPLPD217

Top

Fusion breakpoint peptide structures of MPRIP-BAZ2A

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
5541LRNIRSKPLPDFSRMPRIPBAZ2Achr1717083402chr12569991113045

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of MPRIP-BAZ2A

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN5541LRNIRSKPLPDFSR-7.15543-7.26883
HLA-B14:023BVN5541LRNIRSKPLPDFSR-4.77435-5.80965
HLA-B52:013W395541LRNIRSKPLPDFSR-6.80875-6.92215
HLA-B52:013W395541LRNIRSKPLPDFSR-4.20386-5.23916
HLA-A11:014UQ25541LRNIRSKPLPDFSR-7.5194-8.5547
HLA-A11:014UQ25541LRNIRSKPLPDFSR-6.9601-7.0735
HLA-A24:025HGA5541LRNIRSKPLPDFSR-7.52403-7.63743
HLA-A24:025HGA5541LRNIRSKPLPDFSR-5.82433-6.85963
HLA-B27:056PYJ5541LRNIRSKPLPDFSR-3.28285-4.31815
HLA-B44:053DX85541LRNIRSKPLPDFSR-5.91172-6.94702
HLA-B44:053DX85541LRNIRSKPLPDFSR-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of MPRIP-BAZ2A

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
MPRIP-BAZ2Achr1717083402chr12569991111020RSKPLPDFSRAGGTCCAAGCCCCTGCCTGACTTCTCACGA
MPRIP-BAZ2Achr1717083402chr12569991111021RSKPLPDFSRVAGGTCCAAGCCCCTGCCTGACTTCTCACGAGTC
MPRIP-BAZ2Achr1717083402chr12569991111221KPLPDFSRVAAGCCCCTGCCTGACTTCTCACGAGTC
MPRIP-BAZ2Achr1717083402chr1256999111615LRNIRSKPLCTCAGAAACATCAGGTCCAAGCCCCTG
MPRIP-BAZ2Achr1717083402chr1256999111918IRSKPLPDFATCAGGTCCAAGCCCCTGCCTGACTTC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
MPRIP-BAZ2Achr1717083402chr1256999111116CVTRQLRNIRSKPLPTGTGTCACCCGGCAACTCAGAAACATCAGGTCCAAGCCCCTGCCT
MPRIP-BAZ2Achr1717083402chr1256999111217VTRQLRNIRSKPLPDGTCACCCGGCAACTCAGAAACATCAGGTCCAAGCCCCTGCCTGAC
MPRIP-BAZ2Achr1717083402chr1256999111318TRQLRNIRSKPLPDFACCCGGCAACTCAGAAACATCAGGTCCAAGCCCCTGCCTGACTTC
MPRIP-BAZ2Achr1717083402chr1256999111419RQLRNIRSKPLPDFSCGGCAACTCAGAAACATCAGGTCCAAGCCCCTGCCTGACTTCTCA

Top

Information of the samples that have these potential fusion neoantigens of MPRIP-BAZ2A

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
BLCAMPRIP-BAZ2Achr1717083402ENST00000341712chr1256999111ENST00000179765TCGA-G2-A3VY

Top

Potential target of CAR-T therapy development for MPRIP-BAZ2A

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to MPRIP-BAZ2A

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to MPRIP-BAZ2A

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource